The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role ...

Purdue Pharma and the Sackler family reach a $7.4 billion settlement over their role in the US opioid crisis. The deal, increasing the previous offer by $1.4 billion, ends Sackler control of Purdue ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

This settlement is among the largest in recent years as lawsuits seek to hold companies accountable for the US opioid epidemic.

The U.S. Food and Drug Administration (“FDA”), in partnership with the Department of Justice (“DOJ”), pursued significant and, in some ...

Will Other States Settle with Purdue Pharma? Sackler Family and Purdue ... to seek a more favourable settlement or push forward with trials that could result in additional legal action. As the courts ...

The New York Times reports that the tentative $7.4 billion agreement with 15 states would also require those states to set aside as much as $800 million in what amounts to a legal defense fund for the ...

A federal grand jury charged seven people with running a multi-state conspiracy attempting to defraud the United States for ...

Also, the Sacklers increased their settlement offer, with a catch. Here’s the latest at the end of Thursday.